
In Gold We Trust: What Surging Metals Say About a Shaky Economy
Merryn Talks Money
00:00
AstraZeneca US listing and cross-border stamp duty comparisons
John notes AstraZeneca's US listing move as a test case showing how US listings can avoid UK stamp duty and attract investors.
Transcript
Play full episode